PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Sep-2024 CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program CureVac
12-Sep-2024 ABPI response to the Darzi Review: innovation must be at the heart of improvement ABPI
12-Sep-2024 Biocomposites to distribute its NanoBone® product range in the UK Biocomposites
12-Sep-2024 Epitopea Awarded Grant from Innovate UK’s Cancer Therapeutics Programme Epitopea
12-Sep-2024 KADANS SCIENCE PARTNER WELCOMES NEW TENANT MYRICX BIO TO LONDON INNOVATION CENTRE AT CANARY WHARF Kadans Science Partner
12-Sep-2024 Arctoris acquires Eli Lilly ‘Life Science Studio’ laboratory Arctoris
12-Sep-2024 Vapourtec invests in future with Bristol CDT partnership Vapourtec
12-Sep-2024 QL Biopharm Presented Results from Phase 1c Clinical Study on its Novel Once-Monthly GLP-1RA ZT002 at EASD 2024 Beijing QL Biopharmaceutical Co., Ltd
12-Sep-2024 Moderna R&D Day Highlights Progress and Strategic Priorities AccessWire
12-Sep-2024 Birmingham Health Partners Centre for Regulatory Science and Innovation director appointed University of Birmingham
12-Sep-2024 PharmaSGP continues dynamic growth path in the first half of 2024 PharmaSGP Holding SE
12-Sep-2024 PharmaSGP Holding SE resolves on public share repurchase offer to buy back own shares for up to 594,405 shares PharmaSGP Holding SE
12-Sep-2024 T-Cell Therapy Market to Exhibit a Remarkable 23.8% CAGR: Industry Share, Size, Demand, Trends, Business Growth Acumen Research and Consulting
12-Sep-2024 Choosing the Right Clinical Research Institute: A Step-by-Step Guide with Fusion Technology Solutions Fusion technology solutions
11-Sep-2024 Dr. Amir Bajoghli and Skin & Laser Dermatology Center Offer Advanced Vitiligo Treatment Options AccessWire
11-Sep-2024 Grey Wolf Animal Health to Present at the 2024 Planet MicroCap Showcase in Vancouver AccessWire
11-Sep-2024 Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million AccessWire
11-Sep-2024 Candid Health Announces $29 Million Series B Led by 8VC to Transform Revenue Cycle Automation AccessWire
11-Sep-2024 Curtiss Dentistry Introduces Planmeca Same-Day Dentistry in Maryville, TN AccessWire
11-Sep-2024 SMC accepts bispecific antibody TECVAYLI®▼ (teclistamab) for eligible patients with relapsed and refractory multiple myeloma Johnson & Johnson